Unmet needs in atopic dermatitis management: an expert consensus.

IF 2.9 4区 医学 Q2 DERMATOLOGY
Journal of Dermatological Treatment Pub Date : 2022-08-01 Epub Date: 2021-08-27 DOI:10.1080/09546634.2021.1967267
Annalisa Patrizi, Antonio Costanzo, Cataldo Patruno, Valentina Maria Busà, Andrea Chiricozzi, Giampiero Girolomoni
{"title":"Unmet needs in atopic dermatitis management: an expert consensus.","authors":"Annalisa Patrizi,&nbsp;Antonio Costanzo,&nbsp;Cataldo Patruno,&nbsp;Valentina Maria Busà,&nbsp;Andrea Chiricozzi,&nbsp;Giampiero Girolomoni","doi":"10.1080/09546634.2021.1967267","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Atopic dermatitis (AD) has substantial negative impact on patients' quality of life. Although considerable advances have been made in understanding the pathogenesis and its treatment, there is still limited transfer of this knowledge into daily management. Aiming to identify unmet needs in clinical management of patients with AD, we used a Delphi consensus process.</p><p><strong>Methods: </strong>A set of statements regarding diagnosis, management, prognosis, and treatment was identified by five experts (Steering Committee). Then, the Steering Committee and a second group of four clinicians were involved in a Delphi process. Lastly, agreement was assessed in a larger panel of Italian clinicians.</p><p><strong>Results: </strong>Overall, 37 clinicians participated to the process. 17 statements reached strong agreement and 2 reached weak agreement.</p><p><strong>Conclusions: </strong>In general, the statements reflected the need for accurate and effective diagnostic criteria to support clinical experience, especially in the atypical forms of AD. Moreover, prognostic criteria are needed to predict the duration of adult-onset AD. The identification of biomarkers was considered to be useful for clinical management of AD at all stages of disease. Lastly, greater emphasis should be placed on patient education and development of effective tools that can aid informing patients about their disease and its treatment.</p>","PeriodicalId":15639,"journal":{"name":"Journal of Dermatological Treatment","volume":" ","pages":"2459-2465"},"PeriodicalIF":2.9000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dermatological Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09546634.2021.1967267","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/8/27 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 7

Abstract

Introduction: Atopic dermatitis (AD) has substantial negative impact on patients' quality of life. Although considerable advances have been made in understanding the pathogenesis and its treatment, there is still limited transfer of this knowledge into daily management. Aiming to identify unmet needs in clinical management of patients with AD, we used a Delphi consensus process.

Methods: A set of statements regarding diagnosis, management, prognosis, and treatment was identified by five experts (Steering Committee). Then, the Steering Committee and a second group of four clinicians were involved in a Delphi process. Lastly, agreement was assessed in a larger panel of Italian clinicians.

Results: Overall, 37 clinicians participated to the process. 17 statements reached strong agreement and 2 reached weak agreement.

Conclusions: In general, the statements reflected the need for accurate and effective diagnostic criteria to support clinical experience, especially in the atypical forms of AD. Moreover, prognostic criteria are needed to predict the duration of adult-onset AD. The identification of biomarkers was considered to be useful for clinical management of AD at all stages of disease. Lastly, greater emphasis should be placed on patient education and development of effective tools that can aid informing patients about their disease and its treatment.

特应性皮炎管理中未满足的需求:专家共识。
引言:特应性皮炎(AD)对患者的生活质量有实质性的负面影响。尽管在了解其发病机制及其治疗方面取得了相当大的进展,但将这些知识转移到日常管理中仍然有限。为了确定阿尔茨海默病患者临床管理中未被满足的需求,我们使用了德尔菲共识过程。方法:由五位专家(指导委员会)就诊断、管理、预后和治疗等方面提出一套意见。然后,指导委员会和第二组四名临床医生参与德尔菲过程。最后,在一个更大的意大利临床医生小组中评估了协议。结果:总共有37名临床医生参与了这一过程。17项声明达成强烈一致,2项声明达成弱一致。结论:总的来说,这些陈述反映了需要准确有效的诊断标准来支持临床经验,特别是在非典型形式的AD。此外,需要预后标准来预测成人发病AD的持续时间。生物标志物的鉴定被认为对阿尔茨海默病各个阶段的临床管理有用。最后,应更加重视患者教育和开发有效工具,帮助患者了解其疾病及其治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.50
自引率
0.00%
发文量
145
审稿时长
6-12 weeks
期刊介绍: The Journal of Dermatological Treatment covers all aspects of the treatment of skin disease, including the use of topical and systematically administered drugs and other forms of therapy. The Journal of Dermatological Treatment is positioned to give dermatologists cutting edge information on new treatments in all areas of dermatology. It also publishes valuable clinical reviews and theoretical papers on dermatological treatments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信